Construction of a Chimeric Secretory IgA and Its Neutralization Activity against Avian Influenza Virus H5N1
Figure 3
Western blot analysis of recombinant SIgA under reduced conditions. Transferred proteins were incubated with various specific primary antibodies. (a) Mouse anti-human IgA α-chain. (b) Mouse anti-human κ-chain. (c) Mouse anti-human SC. (d) Mouse anti-human J chain. HRP-conjugated goat anti-mouse IgG was used as secondary antibody. Lane 1: human saliva (positive control); 2: produced SIgA.
